Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease

NCT01438021 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Leptomeningeal Metastases

Interventions

OTHER: pharmacological study
DRUG: methotrexate

Sponsor

City of Hope Medical Center

Collaborators

[object Object]